| Date | Title | Description |
| 26.08.2026 | Genetically Modified Mice Market to Reach USD 2.74 Billion by 2030 | The global Genetically modified mice Market is projected to grow from USD 1.70 billion in 2025 to USD 2.74 billion by 2030, registering a CAGR of 10.0% during the forecast period. Market growth is being driven by the increasing use of mice ... |
| 19.08.2026 | Pharmaceutical Contract Manufacturing Market to Reach USD 311.95 Billion by 2030 | The global Pharmaceutical Contract Manufacturing Market is projected to grow from USD 209.90 billion in 2025 to USD 311.95 billion by 2030, registering a CAGR of 8.2% during the forecast period. Growth is being driven by the increasing outs... |
| 24.03.2026 | Enamine Joins Agora Open Science Trust and Variational AI to Advance Open-Science Discovery of PRMT6 Inhibitors | KYIV, UKRAINE, March 24, 2026 /EINPresswire.com/ -- Enamine, a leading integrated drug discovery contract research organization (CRO) has today announced its participation in an open-science collaboration with Variational AI and the Agora O... |
| 19.02.2026 | ITSX Summit | Just Two Weeks to Go! | DIGIT’s ITSX Summit returns to Dynamic Earth in Edinburgh in just two weeks – register now!
Taking place on 5 March, the conference will contextualise the evolution of the service desk and the future of customer experience and IT support.
T... |
| 11.11.2025 | Demeetra AgBio's CleanCut GS CHO Cells Achieve Dual Viral Clearance Validation, Confirming GMP-Ready Status | Dual viral clearance validation positions CleanCut GS CHO as a GMP-ready, high-productivity platform for biopharma and CDMOs.
LEXINGTON, Ky., Nov. 11, 2025 /PRNewswire-PRWeb/ -- Demeetra announced today that its flagship CleanCut GS CHO cel... |
| 09.10.2025 | Scotland Women in Technology Reveals 2025 Awards Finalists | Scotland Women in Technology (SWiT) has announced the shortlist for its 2025 awards, with Glasgow and Edinburgh competing head-to-head with the most finalists.
Announced during a shortlisting event at JPMorgan Chase in Glasgow earlier tonig... |
| 05.10.2025 | Stock futures are little changed after a record-setting week as government shutdown continues: Live updates | Stock futures were little changed Sunday night as a U.S. government shutdown continued following a week in which Wall Street rallied to record highs.
Dow Jones Industrial Average futures ticked 37 points higher, or 0.1%. S&P 500 futures... |
| 02.09.2025 | AI-driven drug discovery picks up as FDA pushes to reduce animal testing | Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near future.
Within the next three to five years, using ... |
| 22.07.2025 | Dow futures pop more than 200 points after Trump announces Japan trade deal: Live updates | Stock futures rose Wednesday after President Donald Trump announced the U.S. had reached a trade deal with Japan, lifting hope for further agreements being made.
Futures linked to the Dow Jones Industrial Average traded 217 points higher, o... |
| 22.07.2025 | - | Biotechnology and life sciences companies face unique operational and logistical challenges as they scale, which can distract them from the development of impactful therapeutics and biotechnologies. Incubator-style shared laboratory environ... |
| 04.06.2025 | Akadeum Life Sciences Raises $20M+ in Funding | Akadeum Life Sciences, an Ann Arbor, MI-based company which specializes in buoyancy-based cell separation technology, raised $20M+ in funding.
The round was led by Michigan Capital Network, with participation from Arboretum Ventures, NYBC V... |
| 15.02.2025 | Cure Rare Disease: $5.69 Million CIRM Grant Awarded | Cure Rare Disease (CRD) announced it was awarded a $5.69 million grant from the California Institute for Regenerative Medicine (CIRM) to advance the development of an antisense oligonucleotide therapy for spinocerebellar ataxia type 3 (SCA3... |
| 24.01.2025 | ELRIG announces Drs Jue Wang and Robert Grundy as keynote speakers at Research & Innovation 2025 | • ELRIG Research & Innovation 2025 takes place in London, UK from 10–11 March
• Event will focus on ‘Big molecules to big data…thinking BIG to drive innovative research’
Cambridge, UK, 24 January 2025: The European Laboratory Research &... |
| 09.01.2025 | Deciphex: $32.3 Million (Series C) Raised For Addressing The Global Pathology Crisis | Deciphex, an AI-based digital pathology leader, announced it has closed its Series C funding at $32.3 million to address the acute global pathology crisis. Led by Molten Ventures with significant participation from ACT Venture Capital, Sero... |
| 07.01.2025 | Deciphex Secures $32.3M Series C to Address Global Pathology Shortage | DUBLIN–(BUSINESS WIRE)–January 7, 2025–
Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising $32.3 million to address the acute global pathology crisis. Led by Molten Ventures with significant parti... |
| 17.10.2024 | Digital Transformation 2024 Summit | Just One Week To Go! | We are now just one week away from the Digital Transformation Summit, held on Thursday 24th October at Dynamic Earth in Edinburgh.
DT2024 will contextualise the key technology trends and industry disruption amidst a backdrop of significant ... |
| 10.10.2024 | Digital Transformation 2024 Summit | Just Two Weeks to Go! | We are now just two weeks away from the Digital Transformation (DT) 2024 Summit, held on Thursday 24th October at Dynamic Earth in Edinburgh.
DT2024 will contextualise the key technology trends and industry disruption amidst a backdrop of s... |
| 17.09.2024 | CEBINA and Charles River Laboratories announce strategic collaboration to accelerate neuroscience research | VIENNA, VIENNA, AUSTRIA, September 17, 2024 /EINPresswire.com/ -- CEBINA GmbH, Central European Biotech Incubator and Accelerator, and Charles River Laboratories International, Inc. (NYSE: CRL), announce today a strategic collaboration with... |
| 07.08.2024 | Morning Bid: BOJ eases market migraine, Super Micro aches | A look at the day ahead in U.S. and global markets from Mike Dolan
In an extraordinary round trip over the past week, world markets have rebounded sharply from days of turbulence - thanks in part to Bank of Japan almost apologising on Wedne... |
| 26.07.2024 | The AI Revolution: Transforming Search Engines and Pharmaceutical Research | In the digital age, two industries are undergoing seismic shifts: search engines and pharmaceutical research. Both are harnessing the power of artificial intelligence (AI) to redefine their landscapes. The competition is fierce, and the sta... |
| 22.07.2024 | Can AI increase the pace and quality of pharmaceutical research? VeriSIM Life says yes | Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More
We’ve already seen how AI can be used to help uncover the structure of proteins and discover new materials, so it... |
| 13.03.2024 | Epic Bio to Present at the Upcoming Charles River Cell and Gene Therapy Summit | - |
| 13.03.2024 | M-Files Leverages Automation and AI to Revolutionize the Workplace in 2023 | Building on Centaur Status, M-Files Enables Knowledge Workers to Work Smarter
M-Files, the leader in knowledge work automation, announced that the company grew its annual recurring revenue (ARR) in 2023 by more than 20 percent, driven by a ... |
| 09.03.2024 | Host Cell Protein Testing Market to Reach USD 1.99 Billion by 2030 – Exclusive Report By SNS Insider | Host Cell Protein Testing Market
Host Cell Protein Testing Market Analysis, Size, Trends, Industry Overview and Growth Outlook AUSTIN, TEXAS, UNITED STATES, March 9, 2024 /EINPresswire.com/ -- The Global Host Cell Protein Testing Market is ... |
| 03.01.2024 | A biomed company wanted to house 43,000 monkeys near Houston. The neighbors were not happy. | Health A biomed company wanted to house 43,000 monkeys near Houston. The neighbors were not happy.
Polly Thompson
2024-01-03T12:00:17Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The letter F.
Facebook Email icon An envel... |
| 09.11.2023 | Eli Lilly tries a rare tactic: competing on price | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning, everyone. Damian here with a counterintuitive idea in pharma, an ode to scientific matrimony, and the ... |
| 25.09.2023 | Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica | Logica, an offering from Charles River and Valo Health, will be used to discover first-in-class therapeutics against high value targets in the Related Sciences portfolio
Charles River Laboratories International, and Related Sciences (“RS”),... |
| 07.09.2023 | Чем банан из магазина отличается от того, что ели наши предки? Всем | Как селекция меняет привычные нам продукты. Объясняем на примерах с бананами и овцами.
Человек веками выбирал среди растений и животных наиболее полезные качества и культивировал их. Так, например, появились зерновые, которые дают больший у... |
| 01.03.2023 | ATEM Structural Discovery Announces Opening of a Cryo-EM lab in Germany | The laboratory is equipped with two electron-microscopes.
In Q2 2023, the laboratory will be one of the few offering cryo-EM under GMP regulations.
We now established a highly efficient cryo-EM platform that is specifically dedicated to ind... |
| 25.01.2023 | Dublin's Deciphex rakes in €3.9 million to bring AI to more pathology labs | Irish digital pathology startup Deciphex extended its series B round to €14.4 million after raising €3.9 million led by Seroba Life Sciences and its existing investors.
In conjunction with the extended series B round, Seroba partner Jennife... |
| 19.05.2022 | Irish AI-driven pathology startup nabs $11.5 million | Pathology is heading for a crunch point due to increasing volumes, increasing complexity and flat to declining pathologist numbers. Clinical pathologists are limited assets worldwide, and their number is predicted to significantly decrease ... |
| 20.04.2022 | Charles River Laboratories and NLC Collaborate | PRESS RELEASE
April 2022
NLC – The European Healthtech Venture Builder and Charles River Laboratories team up to drive drug discovery projects towards finding innovative therapeutics.
Charles River Laboratories (“Charles River”) and NLC-... |
| 22.03.2022 |
Quantum Computers vs. Crypto Mining: Separating Facts From Fiction | Quantum computers are special machines that can perform certain calculations significantly faster than everyday computers – known as “classical computers” – and represent the next frontier in computation technology.
In recent years, there h... |
| 23.11.2021 | Zero2.5 natural fiber air ionizers inactivate 99.998% of COVID-19 virus, independent test shows | SINGAPORE, Nov. 23, 2021 /PRNewswire/ -- As of May 2021, the World Health Organization has officially recognized aerosolized particles as a mode of transmission for COVID-19.
Zero2.5 Natural Fiber Air Ionizer Series - CF4000 and the derivat... |
| 09.11.2021 | Charles River Laboratories International, Inc. at Credit Suisse 30th Annual Healthcare Conference Presentation | Credit Suisse 30th Annual Healthcare Conference
November 9, 2021
Charles River Laboratories
Birgit Girshick
Corporate Executive Vice President, Discovery &
Safety Assessment and Biologics Solutions
EVERY STEP OF THE WAY © 2021 Charles R... |
| 03.11.2021 | Charles River Laboratories Q3 2021 Earnings Presentation | 3Q 2021 Results
November 3, 2021
Charles River Laboratories
EVERY STEP OF THE WAY © 2021 Charles River Laboratories International, Inc.
Safe Harbor Statement
Caution Concerning Forward-Looking Statements. This presentation includes forward-... |
| 13.10.2021 | Charles River Laboratories has been on an acquisition spree. But Tuesday, it offloaded two assets | Following a summer filled with mergers and acquisitions, Charles River Laboratories has divested its research operations in Japan and a CDMO site in Sweden, engineering two separate deals expected to cut down $20 ... |
| 01.09.2021 | Single Cell Discoveries joins consortium to build a single-cell cancer atlas to find therapy resistant tumor cells | |
| 07.06.2021 | Charles River Laboratories International : Announces Long-Term Solar Contract for North American Operations | Commits to sourcing 100% renewable electricity and reducing 50% of greenhouse gas emissions from facilities by 2030
WILMINGTON, Mass.--(BUSINESS WIRE)--Jun. 7, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) today announce... |
| 07.06.2021 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Charles River Laboratories International : Announces Long-Term Solar Contract for North American Operations | Commits to sourcing 100% renewable electricity and reducing 50% of greenhouse gas emissions from facilities by 2030
WILMINGTON, Mass.--(BUSINESS WIRE)--Jun. 7, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) today announce... |
| 06.04.2021 | In 1-2 punch, Molecular Templates cuts first-gen candidate and loses a Big Pharma partner; Charles River teams up with Valence to provide AI discovery platform | It’s been several months since a treatment-related death led the FDA to put a partial hold on Molecular Templates’ only first-generation engineered toxin body (ETB) candidate. Now the company is nixing the program, a... |
| 29.03.2021 | Charles River Laboratories Completes the Acquisition of Cognate BioServices | Mar 29 2021
WILMINGTON, Mass.—(BUSINESS WIRE)—Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of Cognate BioServices, Inc. for approximately $875 million... |
| 17.02.2021 | Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development | Feb 17 2021
– Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector –
– Combines Cognate’s Comprehensive Cell and Gene Therapy CDMO Capabilities to Establish an Integrated Solution f... |
| 14.06.2020 | Bit Bio’s ‘enter button for the keyboard to the software of life’ nabs the company $41.5 million | Bit Bio, the new startup that pitches itself as the “enter button for the keyboard to the software of life,” only needed three weeks to raise its latest $41.5 million round of funding.
Originally known as Elpis Biotechnology and named for t... |
| 21.01.2020 | Cognate BioServices closes Series B and completes acquisition of Cobra Biologics | Jan 21 2020
MEMPHIS, Tennessee—Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products today announced that it has completed the acquisition of C... |
| 03.05.2019 | Boston Tech Watch: Wayfair Tumbles, Charles River Leaks & Chewy Begs | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
First quarter losses jolt Wayfair shareholders. Liberty Mutual teams up with MIT’s new AI research college. Charles River Labs reports its systems were hacked. Read on for mor... |
| 01.05.2019 | CRO Charles River Labs hacked, data from clients stolen | CRL spokeswoman Amy Cianciaruso said in a phone interview that the SEC filing contained all the information the company would disclose publicly about the incident. However, she noted that because the CRO focuses on preclinical and drug disc... |
| 05.10.2017 | SpiroChem ready for further growth | |
| 20.11.2015 | Charles River Laboratories International Acquires Oncotest for €34M | Charles River Laboratories International, Inc. (NYSE: CRL), a Wilmington, Massachusetts-based provider of essential products and services to accelerate research and drug development efforts, acquired Oncotest GmbH, a Freiburg, Germany-based... |
| 10.09.2012 | Avista Capital Partners Appoints Brian A. Markison Healthcare Industry Executive | New York, NY, Sept. 10, 2012 – Avista Capital Partners today announced that Brian A. Markison has joined the firm as a healthcare Industry Executive. Mr. Markison has more than 30 years of experience in the pharmaceuticals sector, most rece... |
| 10.09.2012 | Researchers seek food industry help to develop next generation of brain foods | The long-term plan is to incorporate the ingredient - dubbed neuroptin - into medical foods, said Dr Daryl Thompson, director of Florida-based biomedical research group Global Research and Discovery Group.
Thompson, who has been researchin... |
| 30.08.2012 | Biopharma CSO with biological testing, cell banking raises $2.9M | Location: Malvern, Pennsylvania
Solution/product: It provides support services for biotechnology and pharmaceutical companies, among them: biological safety testing, such as antibiotic resistance testing, cell bank manufacturing and DNA seq... |
| 30.07.2010 | CRL spikes $1.6 billion WuXi merger over shareholder concerns | Charles River Laboratories International Inc. (NYSE:CRL) will leave WuXi PharmaTech (Cayman) Inc. (NYSE:WX) at the altar and take its $1.6 billion dowry with it, after failing to convince shareholders that the union was in the best interest... |
| 15.06.2010 | Charles River Labs to hedge fund: WuXi deal too good to pass up | Charles River Laboratories International Inc. (NYSE:CRL) responded to its largest shareholder’s protest about a proposed merger with Shanghai-based WuXi PharmaTech (Cayman) Inc. (NYSE:WX), saying the deal was too good to pass up.
In a lette... |
| 15.06.2010 | Charles River Laboratories rebuffs investors protesting WuXi PharmaTech deal | Charles River Laboratories International Inc. (NYSE:CRL) responded to its largest shareholder’s protest about a proposed merger with Shanghai-based WuXi PharmaTech (Cayman) Inc. (NYSE:WX), saying the deal was too good to pass up.
In a lette... |
| 23.03.2010 | UPDATE: Charles River Labs exec to bow out for Canadian CEO spot | Less than a year after a reorganization put him in charge of Charles River Laboratories International Inc.’s (NYSE:CRL) global preclinical services in North American and China, senior vice president Christopher Perkin is planning to leave t... |
| 11.01.2010 | Charles River Labs to lay off nearly 300 workers in Shrewsbury | Charles River Laboratories International Inc. (NYSE:CRL) suspended operations at its preclinical services unit in Shrewsbury, a move that will result in about 300 layoffs.
About 30 of the 300 employees will be kept on to maintain the facili... |
| 17.12.2007 | Avista Capital Partners Agrees To Acquire Bristol-Myers Squibb Medical Imaging For Approximately $525 Million | New York, NY, December 17, 2007 – Bristol-Myers Squibb Company (NYSE: BMY) and Avista Capital Partners, a leading private equity firm, announced today the parties have signed a definitive agreement for Avista to acquire Bristol-Myers Squibb... |
| 13.12.2007 | Boston Scientific Agrees to Sell Fluid Management And Venous Access Business To Avista Capital Partners for $425 Million | Natick, MA and New York, NY December 13, 2007 – Boston Scientific Corporation (NYSE: BSX) and Avista Capital Partners, a leading private equity firm, today jointly announced the signing of a definitive agreement under which Avista will acqu... |
| 17.10.2007 | Avista Capital Partners bolsters healthcare practice with appointments of Charles Harwood and Ron Sparks | New York, NY, October 17, 2007 – Avista Capital Partners, a leading private equity firm, today announced that it has hired Charles C. Harwood, Jr., a proven operator in the clinical diagnostics and pharmaceutical services industries, and Ro... |
| 12.04.2007 | Avista Capital Partners completes acquisition Of Bioreliance Corporation from Invitrogen Corporation | New York, NY, April 12, 2007 – Avista Capital Partners, a leading private equity firm, announced today it has completed its acquisition of BioReliance Corporation, a business unit of Invitrogen Corporation (NASDAQ: IVGN) for approximately $... |
| 13.02.2007 | Avista Capital Partners agrees to acquire Bioreliance Corporation for approximately $210 million | New York, NY, February 13, 2007 – Avista Capital Partners, a leading private equity firm, announced today it has signed a definitive agreement to acquire BioReliance Corporation, a business unit of Invitrogen Corporation (NASDAQ: IVGN) for ... |
| - | Irish AI-driven pathology startup nabs $11.5 million | Pathology is heading for a crunch point due to increasing volumes, increasing complexity and flat to declining pathologist numbers. Clinical pathologists are limited assets worldwide, and their number is predicted to significantly decrease ... |
| - | Avista Capital Partners Appoints Hakan Bjorklund As Healthcare Operating Executive | Departing Nycomed CEO Bolsters Leading Private Equity Healthcare Practice
New York, NY, October 3, 2011 – Avista Capital Partners, a leading private equity firm, today announced that it has hired Håkan Björklund, the departing Chief Execut... |
| - | Biopharma CSO with biological testing, cell banking raises $2.9M | Company Name: Benten BioServices
Industry: Biopharmaceutical
Location: Malvern, Pennsylvania
Solution/product: It provides support services for biotechnology and pharmaceutical companies, among them: biological safety testing, such as antib... |
| - | Charles River Laboratories Completes the Acquisition of MPI Research | WILMINGTON, Mass.–(BUSINESS WIRE)–Apr. 3, 2018– Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of MPI Research for approximately $800 million in cash, su... |
| - | Medicinal chemistry is key to the right compound candidate | Depending on who you ask, drug development costs can range from 1.6 billion to 5 billion dollars by the time the drug hits the market.
Anything that can be done to shorten the timetable — and produce high quality promising candidates — is k... |
| - | Charles River Laboratories rebuffs investors protesting WuXi PharmaTech deal | Charles River Laboratories International Inc. (NYSE:CRL) responded to its largest shareholder’s protest about a proposed merger with Shanghai-based WuXi PharmaTech (Cayman) Inc. (NYSE:WX), saying the deal was too good to pass up.
In a lette... |
| - | CRO Charles River Labs hacked, data from clients stolen | One of the largest contract research organizations in the world said it was hacked and that data from companies using its services were stolen.
In a Securities and Exchange Commission filing Tuesday, Wilmington, Massachusetts-based Charles ... |
